SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001400482-15-000094
Filing Date
2015-11-13
Accepted
2015-11-12 17:42:25
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2015093010-q.htm 10-Q 684195
2 EXHIBIT 31.1 acucela-20150930xexhibit311.htm EX-31.1 11397
3 EXHIBIT 31.2 acucela-20150930xexhibit312.htm EX-31.2 11352
4 EXHIBIT 32.1 acucela-20150930xexhibit321.htm EX-32.1 6237
5 EXHIBIT 32.2 acucela-20150930xexhibit322.htm EX-32.2 6073
  Complete submission text file 0001400482-15-000094.txt   2818277

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acuc-20150930.xml EX-101.INS 426586
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acuc-20150930.xsd EX-101.SCH 24442
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acuc-20150930_cal.xml EX-101.CAL 48808
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acuc-20150930_def.xml EX-101.DEF 80960
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acuc-20150930_lab.xml EX-101.LAB 313455
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acuc-20150930_pre.xml EX-101.PRE 167553
Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Filer) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55133 | Film No.: 151226133
SIC: 2834 Pharmaceutical Preparations